BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 18809147)

  • 1. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.
    Keating KM; Brewer NT; Gottlieb SL; Liddon N; Ludema C; Smith JS
    J Adolesc Health; 2008 Oct; 43(4 Suppl):S61-7. PubMed ID: 18809147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability of human papillomavirus vaccine at medical practices in an area with elevated rates of cervical cancer.
    Gottlieb SL; Brewer NT; Smith JS; Keating KM; Markowitz LE
    J Adolesc Health; 2009 Nov; 45(5):438-44. PubMed ID: 19837349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
    Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
    Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
    Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
    Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India.
    Krupp K; Marlow LA; Kielmann K; Doddaiah N; Mysore S; Reingold AL; Madhivanan P
    J Adolesc Health; 2010 Apr; 46(4):379-84. PubMed ID: 20307828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists.
    Young JL; Bernheim RG; Korte JE; Stoler MH; Guterbock TM; Rice LW
    J Pediatr Adolesc Gynecol; 2011 Dec; 24(6):380-5. PubMed ID: 21906978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer.
    Gottlieb SL; Brewer NT; Sternberg MR; Smith JS; Ziarnowski K; Liddon N; Markowitz LE
    J Adolesc Health; 2009 Nov; 45(5):430-7. PubMed ID: 19837348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving adolescent health: focus on HPV vaccine acceptance.
    Zimet GD
    J Adolesc Health; 2005 Dec; 37(6 Suppl):S17-23. PubMed ID: 16310137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the barriers to HPV vaccination in high-risk populations in the US.
    Downs LS; Scarinci I; Einstein MH; Collins Y; Flowers L
    Gynecol Oncol; 2010 Jun; 117(3):486-90. PubMed ID: 20303156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV vaccine acceptability in Ghana, West Africa.
    Coleman MA; Levison J; Sangi-Haghpeykar H
    Vaccine; 2011 May; 29(23):3945-50. PubMed ID: 21481327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings.
    Bingham A; Drake JK; LaMontagne DS
    Arch Pediatr Adolesc Med; 2009 May; 163(5):455-61. PubMed ID: 19414692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial lessons learned in HPV vaccination.
    Herzog TJ; Huh WK; Downs LS; Smith JS; Monk BJ
    Gynecol Oncol; 2008 May; 109(2 Suppl):S4-11. PubMed ID: 18482557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.
    Wong LP
    J Low Genit Tract Dis; 2009 Apr; 13(2):85-93. PubMed ID: 19387128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and concerns related to the human papillomavirus vaccine among underserved Latina women.
    Wu JP; Porch E; McWeeney M; Ohman-Strickland P; Levine JP
    J Low Genit Tract Dis; 2010 Jul; 14(3):155-61. PubMed ID: 20592548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding and overcoming barriers to human papillomavirus vaccine acceptance.
    Zimet GD
    Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s23-8. PubMed ID: 16520681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental acceptance of Human Papillomavirus vaccines.
    Lenselink CH; Gerrits MM; Melchers WJ; Massuger LF; van Hamont D; Bekkers RL
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):103-7. PubMed ID: 17368910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination.
    Cooper Robbins SC; Bernard D; McCaffery K; Brotherton J; Garland S; Skinner SR
    Vaccine; 2010 Apr; 28(19):3398-408. PubMed ID: 20199758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women.
    Sperber NR; Brewer NT; Smith JS
    Cancer Causes Control; 2008 Feb; 19(1):115-8. PubMed ID: 17952620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What affects human papillomavirus vaccination rates? A qualitative analysis of providers' perceptions.
    Perkins RB; Clark JA
    Womens Health Issues; 2012; 22(4):e379-86. PubMed ID: 22609253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.